| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/21/2003 | US6509464 1-Heteroaryl-pyrrolidine, piperidine, or homopiperidine derivates; nervous system disorder treatment; amidation |
| 01/21/2003 | US6509366 Substituted imidazoles as selective modulators of Bradykinin B2 receptors |
| 01/21/2003 | US6509361 1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors |
| 01/21/2003 | US6509352 Selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/21/2003 | US6509346 Chemokine receptor antagonists and methods of use therefor |
| 01/21/2003 | US6509345 For therapy of cancerous diseases |
| 01/21/2003 | US6509341 The invention relates to carboxylic acid derivatives of formula (I), wherein the substituents have the meaning as commented in the description. It also relates to the production and use of same as endothelin receptor antagonists. |
| 01/21/2003 | US6509340 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands |
| 01/21/2003 | US6509339 Gastrointestinal disorders; cardiovascular disorders |
| 01/21/2003 | US6509336 Imidazolyl derivatives |
| 01/21/2003 | US6509331 Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2003 | US6509328 Glutamate receptor antagonists |
| 01/21/2003 | US6508957 Fluorescent maleimides and uses thereof |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2003004491A1 Semicarbazides and their uses |
| 01/16/2003 | WO2003004488A1 Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors |
| 01/16/2003 | WO2003004487A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | WO2003004476A1 Aminoalkyl-substituted benzotriazoles and triazoles as metal deactivators |
| 01/16/2003 | WO2003004475A1 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004028A1 Tetrahydroquinoline derivatives |
| 01/16/2003 | WO2003004027A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | WO2003004023A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 01/16/2003 | WO2003004020A1 Heteroaryl carboxylic acid amides, the production thereof and the use of the same as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 01/16/2003 | WO2003004018A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
| 01/16/2003 | WO2003004007A2 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 01/16/2003 | WO2003004006A2 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | WO2002085857A3 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| 01/16/2003 | WO2002051837A3 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 01/16/2003 | WO2002050062A3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 01/16/2003 | WO2002012196A3 Lactam compounds and their use as inhibitors of serine proteases and method |
| 01/16/2003 | WO2001062705A3 Aminoalcohol derivatives |
| 01/16/2003 | US20030013886 Such as (E)-1-(2-Pyridyl)-2-styryl-1H-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 01/16/2003 | US20030013875 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 01/16/2003 | US20030013874 Non-opioid analgesics for chronic and acute pain; 1-[1-(p-phenylbenzyl)-4-piperidinyl]-2,1,3-benzothiadiazol-2,2-dione; modulation of the opioid and ORL I receptors; agonist or antagonist activity at the CNS mu, delta and kappa receptors greater than morphine |
| 01/16/2003 | US20030013857 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 01/16/2003 | US20030013754 Antiinflamamtory agents |
| 01/16/2003 | US20030013743 Anticancer agents |
| 01/16/2003 | US20030013741 Antihistamines; antiallergens |
| 01/16/2003 | US20030013736 Sexual disorders; melting, cooling cycles; crystallization; bioavailability |
| 01/16/2003 | US20030013727 Therapy for sexual disorders |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013720 Antidiabetic agents; obesity |
| 01/16/2003 | US20030013718 Phthalazine derivatives for treating inflammatory diseases |
| 01/16/2003 | US20030013713 Compounds as PDE IV and TNF-inhibitors |
| 01/16/2003 | US20030013712 Antiinflammatory agents |
| 01/16/2003 | US20030013711 Anticancer agents |
| 01/16/2003 | US20030013708 Therapeutic heterocyclic compounds |
| 01/16/2003 | US20030013700 Thrombin inhibitors |
| 01/16/2003 | CA2454613A1 Substituted anilinic piperidines as mch selective antagonists |
| 01/16/2003 | CA2453104A1 Semicarbazides and their uses |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | CA2452597A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | CA2452392A1 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
| 01/16/2003 | CA2452366A1 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | CA2452211A1 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives as gaba-a receptor ligands |
| 01/15/2003 | EP1275644A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/15/2003 | EP1275301A1 Trisubstituted heterocyclic compounds and their use as fungicides |
| 01/15/2003 | EP1274706A1 Pyrazoles for inhibiting protein kinases |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274692A1 Quinazoline compounds |
| 01/15/2003 | EP1274687A1 1,2,3,4- tetrahydroisoquinoline derivatives |
| 01/15/2003 | EP1274683A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 01/15/2003 | EP1274424A1 Compounds and methods |
| 01/15/2003 | EP1169317B1 Triarylimidazoles |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | EP0925287B1 Heterocyclic metalloprotease inhibitors |
| 01/15/2003 | EP0907643B1 Compounds with growth hormone releasing properties |
| 01/15/2003 | EP0851756B1 Use of ondansetron in the manufacture of a medicament for the treatment of tremor |
| 01/15/2003 | EP0820451B1 Novel heterocyclic compounds |
| 01/15/2003 | EP0754178B1 Novel functionalized hydrophilic acridinium esters |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | EP0722442B1 Polyazacycloalkanes as dichelants |
| 01/15/2003 | EP0659078B1 Anabaseine derivatives useful in the treatment of degenerative diseases of the nervous system |
| 01/15/2003 | EP0649412B1 Pharmaceutical pyridine compounds |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391564A Chemical compounds |
| 01/15/2003 | CN1391563A Therapeutic quinazoline derivatives |
| 01/15/2003 | CN1391562A Quinazoline derivatives as pharmaceuticals |
| 01/15/2003 | CN1391561A Quinazoline compounds and pharmaceutical compositions containing them |
| 01/15/2003 | CN1391560A 喹唑啉衍生物 Quinazoline derivatives |
| 01/15/2003 | CN1391558A Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 01/15/2003 | CN1391557A 6-position substituted indoline, production and use thereof as medicament |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1390835A Preparation of terpyridyl compounds |
| 01/15/2003 | CN1390834A Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 01/15/2003 | CN1098839C Preparation and application of 80-chloroquinolone carboxylic acid derivative |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506901 1-(9H-Carbazol-4-yloxy)-3-((1-(7-trifluoromethyl-quinolin-4-yl) -piperidin-4-lmethyl)-amino)-propan-2-ol, for example; treating diabetes, urinary continence, atherosclerosis, gastrointestinal disorders, glaucoma |
| 01/14/2003 | US6506900 Epoxidation of the 2,2-dithienyl-2-hydroxyacetic acid ester; esterification |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506788 N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders |
| 01/14/2003 | US6506779 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 01/14/2003 | US6506773 Hydroxamic and carboxylic acid derivatives |